Logo image of USCR

U S Concrete Inc (USCR) Stock Fundamental Analysis

NASDAQ:USCR - Nasdaq -

73.99  -0.01 (-0.01%)

After market: 74.04 +0.05 (+0.07%)

Fundamental Rating

1

Overall USCR gets a fundamental rating of 1 out of 10. We evaluated USCR against 12 industry peers in the Construction Materials industry. Both the profitability and financial health of USCR have multiple concerns. USCR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

USCR had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -0.2%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 3.5%
PM (TTM) -0.23%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

USCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

USCR has an Altman-Z score of 1.51. This is a bad value and indicates that USCR is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 1.97 is on the high side and indicates that USCR has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.97
Debt/FCF N/A
Altman-Z 1.51
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.45 indicates that USCR should not have too much problems paying its short term obligations.
A Quick Ratio of 1.11 indicates that USCR should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.11

More info and screens

3

3. Growth

3.1 Past

The earnings per share for USCR have decreased strongly by -75.70% in the last year.
Measured over the past years, USCR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.67% on average per year.
USCR shows a decrease in Revenue. In the last year, the revenue decreased by -7.91%.
The Revenue has been growing slightly by 6.98% on average over the past years.
EPS 1Y (TTM)-75.7%
EPS 3Y-10.83%
EPS 5Y-13.67%
EPS Q2Q%-275.51%
Revenue 1Y (TTM)-7.91%
Revenue growth 3Y0.74%
Revenue growth 5Y6.98%
Sales Q2Q%1.46%

3.2 Future

Based on estimates for the next years, USCR will show a very strong growth in Earnings Per Share. The EPS will grow by 22.40% on average per year.
Based on estimates for the next years, USCR will show a small growth in Revenue. The Revenue will grow by 2.14% on average per year.
EPS Next Y20.4%
EPS Next 2Y22.52%
EPS Next 3Y28.3%
EPS Next 5Y22.4%
Revenue Next Year0.78%
Revenue Next 2Y3.38%
Revenue Next 3Y2.15%
Revenue Next 5Y2.14%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
USCR Yearly Revenue VS EstimatesUSCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
USCR Yearly EPS VS EstimatesUSCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 142.29, USCR can be considered very expensive at the moment.
USCR is valuated expensively when we compare the Price/Earnings ratio to 27.85, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 23.25, which indicates a rather expensive current valuation of USCR.
USCR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.77.
Industry RankSector Rank
PE 142.29
Fwd PE 23.25
USCR Price Earnings VS Forward Price EarningsUSCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.62
USCR Per share dataUSCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
USCR's earnings are expected to grow with 28.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)6.97
PEG (5Y)N/A
EPS Next 2Y22.52%
EPS Next 3Y28.3%

More info and screens

0

5. Dividend

5.1 Amount

USCR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

U S Concrete Inc

NASDAQ:USCR (8/25/2021, 8:08:07 PM)

After market: 74.04 +0.05 (+0.07%)

73.99

-0.01 (-0.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)N/A N/A
Earnings (Next)02-28 2022-02-28/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners12.18%
Ins Owner Change0%
Market Cap1.27B
Analysts60
Price Target70.72 (-4.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 142.29
Fwd PE 23.25
P/S 0.96
P/FCF N/A
P/OCF N/A
P/B 3.34
P/tB N/A
EV/EBITDA 13.62
EPS(TTM)0.52
EY0.7%
EPS(NY)3.18
Fwd EY4.3%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS77.11
BVpS22.15
TBVpSN/A
PEG (NY)6.97
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.2%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 3.5%
PM (TTM) -0.23%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 1.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.11
Altman-Z 1.51
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.7%
EPS 3Y-10.83%
EPS 5Y-13.67%
EPS Q2Q%-275.51%
EPS Next Y20.4%
EPS Next 2Y22.52%
EPS Next 3Y28.3%
EPS Next 5Y22.4%
Revenue 1Y (TTM)-7.91%
Revenue growth 3Y0.74%
Revenue growth 5Y6.98%
Sales Q2Q%1.46%
Revenue Next Year0.78%
Revenue Next 2Y3.38%
Revenue Next 3Y2.15%
Revenue Next 5Y2.14%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A